Raw Plecanatide powder (467426-54-6) video
Raw Plecanatide powder (467426-54-6) Description
Plecanatide powder is a drug approved in January 2017 by the FDA for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation. It is an agonist of guanylate cyclase-C, it increases intestinal transit and fluid through a buildup of cGMP.
Raw Plecanatide powder should not be used in children less than six years of age, and should be avoided in patients six years to 18 years of age.
Raw Plecanatide powder (467426-54-6) Specifications
|Product Name||Plecanatide powder|
|Chemical Name||L-Leucine,L-asparaginyl-L-α-aspartyl-L-α-glutamyl-L-cysteinyl-L-αglutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-Lcysteinyl-, cyclic (4→12),(7→15)-bis(disulfide);Plecanatide Impurtiy; SP-304;|
|Monoisotopic Mass||1680.625 g/mol|
|Biological Half-Life||half-life (t½) cannot be calculated due to negligible systemic absorbance|
|Color||white to off-white|
|Solubility||Water Solubility:0.165 mg/mL|
|Application||Used for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation.|